Natalizumab for multiple sclerosis: appraising risk versus benefit, a seemingly demanding tango.
about
T-cell exhaustion in allograft rejection and toleranceImmune System Involvement in the Pathogenesis of JC Virus Induced PML: What is Learned from Studies of Patients with Underlying Diseases and Therapies as Risk FactorsUse of natalizumab in multiple sclerosis: current perspectives.Immunosuppressive Medications.Perception of risk and shared decision making process in multiple sclerosis.Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
P2860
Natalizumab for multiple sclerosis: appraising risk versus benefit, a seemingly demanding tango.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Natalizumab for multiple scler ...... , a seemingly demanding tango.
@en
type
label
Natalizumab for multiple scler ...... , a seemingly demanding tango.
@en
prefLabel
Natalizumab for multiple scler ...... , a seemingly demanding tango.
@en
P2860
P1476
Natalizumab for multiple scler ...... , a seemingly demanding tango.
@en
P2093
Sahil Gupta
P2860
P304
P356
10.1517/14712598.2014.864634
P407
P577
2013-12-02T00:00:00Z